Graham J Emslie

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. pmc Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8589, USA
    J Child Adolesc Psychopharmacol 22:21-8. 2012
  2. ncbi request reprint Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder
    G J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 75390 8589, USA
    Int J Neuropsychopharmacol 4:159-68. 2001
  3. ncbi request reprint Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 48:721-9. 2009
  4. ncbi request reprint Continuation and maintenance therapy of early-onset major depressive disorder
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas and Children s Medical Center of Dallas, Dallas, Texas, USA
    Paediatr Drugs 7:203-17. 2005
  5. ncbi request reprint A feasibility study of the childhood depression medication algorithm: the Texas Children's Medication Algorithm Project (CMAP)
    Graham J Emslie
    University of Texas Southwestern Medical Center Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 43:519-27. 2004
  6. ncbi request reprint Predictors of response to treatment in children and adolescents with mood disorders
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390 8589, USA
    Psychiatr Clin North Am 26:435-56. 2003
  7. pmc Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 8589, USA
    Am J Psychiatry 165:459-67. 2008
  8. pmc Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes
    Graham J Emslie
    University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 8589, USA
    Am J Psychiatry 167:782-91. 2010
  9. ncbi request reprint Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 45:709-19. 2006
  10. ncbi request reprint Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75235, USA
    J Am Acad Child Adolesc Psychiatry 46:479-88. 2007

Research Grants

Detail Information

Publications55

  1. pmc Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8589, USA
    J Child Adolesc Psychopharmacol 22:21-8. 2012
    ..There are limited data on the impact of insomnia in response to acute treatment, which is particularly relevant with serotonin-selective reuptake inhibitors, given their tendency to worsen sleep architecture...
  2. ncbi request reprint Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder
    G J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 75390 8589, USA
    Int J Neuropsychopharmacol 4:159-68. 2001
    ..Depression in children and adolescents is frequently a chronic, recurrent illness. Factors that can predict clinical course are important in increasing our understanding of depression in this age group...
  3. ncbi request reprint Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 48:721-9. 2009
    ..This article presents the results from a prospective, randomized, double-blind, placebo-controlled trial of escitalopram in adolescent patients with major depressive disorder...
  4. ncbi request reprint Continuation and maintenance therapy of early-onset major depressive disorder
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas and Children s Medical Center of Dallas, Dallas, Texas, USA
    Paediatr Drugs 7:203-17. 2005
    ....
  5. ncbi request reprint A feasibility study of the childhood depression medication algorithm: the Texas Children's Medication Algorithm Project (CMAP)
    Graham J Emslie
    University of Texas Southwestern Medical Center Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 43:519-27. 2004
    ....
  6. ncbi request reprint Predictors of response to treatment in children and adolescents with mood disorders
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390 8589, USA
    Psychiatr Clin North Am 26:435-56. 2003
    ..Such a biopsychosocial approach to treatment of these disorders will likely improve overall outcome...
  7. pmc Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 8589, USA
    Am J Psychiatry 165:459-67. 2008
    ..The authors compared fluoxetine and placebo in continuation treatment to prevent relapse of major depressive disorder in children and adolescents...
  8. pmc Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes
    Graham J Emslie
    University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 8589, USA
    Am J Psychiatry 167:782-91. 2010
    ....
  9. ncbi request reprint Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 45:709-19. 2006
    ..To assess the efficacy and tolerability of paroxetine in pediatric major depressive disorder...
  10. ncbi request reprint Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75235, USA
    J Am Acad Child Adolesc Psychiatry 46:479-88. 2007
    ....
  11. pmc Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder
    Betsy D Kennard
    University of Texas Southwestern Medical Center, Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 47:1395-404. 2008
    ....
  12. ncbi request reprint Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder
    Carroll W Hughes
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 46:667-86. 2007
    ..To revise and update consensus guidelines for medication treatment algorithms for childhood major depressive disorder based on new scientific evidence and expert clinical consensus when evidence is lacking...
  13. ncbi request reprint Do children and adolescents have differential response rates in placebo-controlled trials of fluoxetine?
    Taryn L Mayes
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 8589, USA
    CNS Spectr 12:147-54. 2007
    ....
  14. pmc Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes
    Betsy D Kennard
    5323 Harry Hines Blvd, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 48:186-95. 2009
    ..We examine remission rate probabilities, recovery rates, and residual symptoms across 36 weeks in the Treatment for Adolescents with Depression Study (TADS)...
  15. pmc Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents
    Ira H Bernstein
    Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX 75390 9066, USA
    Int J Methods Psychiatr Res 19:185-94. 2010
    ..This study evaluated both versions of the QIDS and the 17-item Children's Depressive Rating Scale - Revised (CDRS-R) in an adolescent outpatient sample...
  16. pmc Maternal depressive symptoms in pediatric major depressive disorder: relationship to acute treatment outcome
    Betsy D Kennard
    University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 47:694-9. 2008
    ..In the present study, we assess maternal depressive symptoms at the beginning and end of treatment to investigate the possible reciprocal relationship of maternal illness with the child's depressive illness and treatment...
  17. ncbi request reprint Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, Texas, USA
    J Am Acad Child Adolesc Psychiatry 43:1397-405. 2004
    ....
  18. pmc Assessment of safety and long-term outcomes of initial treatment with placebo in TADS
    Betsy D Kennard
    University of Texas Southwestern Medical Center at Dallas, 75390 8589, USA
    Am J Psychiatry 166:337-44. 2009
    ....
  19. pmc Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings
    Betsy D Kennard
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 8589, USA
    J Consult Clin Psychol 77:1033-41. 2009
    ..Finally, social skills and problem solving may be active elements in CBT for adolescent depression and should be considered in treatment by those working with seriously depressed youths...
  20. pmc Psychometric properties of the Children's Depression Rating Scale-Revised in adolescents
    Taryn L Mayes
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8589, USA
    J Child Adolesc Psychopharmacol 20:513-6. 2010
    ..The aim of this study was to present the reliability and validity of the Children's Depression Rating Scale-Revised (CDRS-R) in the adolescent age group...
  21. pmc A psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children
    Shailesh Jain
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    J Am Acad Child Adolesc Psychiatry 46:1204-12. 2007
    ..This study compared the psychometric properties of the Children's Depression Rating Scale-Revised (CDRS-R) and the Montgomery-Asberg Depression Rating Scale (MADRS) in children with major depressive disorder...
  22. ncbi request reprint The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder
    Steven R Pliszka
    Department of Psychiatry, University of Texas Health Science Center at San Antonio, 78229 3900, USA
    J Am Acad Child Adolesc Psychiatry 45:642-57. 2006
    ..Advances in the psychopharmacology of ADHD and results of a feasibility study of algorithm use in community mental health centers caused the algorithm to be modified and updated...
  23. doi request reprint Depression
    Christine J Choe
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 8589, USA
    Child Adolesc Psychiatr Clin N Am 21:807-29. 2012
    ..Further research is needed in the pharmacologic treatment of depressed youth, including expanding the study of non-SSRI antidepressants, augmentation and adjunctive strategies, and treatment in patients with comorbid conditions...
  24. ncbi request reprint Sex and age differences in sleep macroarchitecture in childhood and adolescent depression
    Jennifer J T Robert
    Department of Psychiatry, University of Michigan, Ann Arbor 48105, USA
    Sleep 29:351-8. 2006
    ..To evaluate age and sex differences in sleep macroarchitecture in children and adolescents with major depressive disorder...
  25. pmc Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder
    Rongrong Tao
    University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 8589, USA
    J Child Adolesc Psychopharmacol 20:423-30. 2010
    ....
  26. ncbi request reprint Long-term, open-label venlafaxine extended-release treatment in children and adolescents with major depressive disorder
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
    CNS Spectr 12:223-33. 2007
    ..Yet, data on long-term treatment with antidepressants in pediatric MDD are limited...
  27. ncbi request reprint Relapse and recurrence in pediatric depression
    Betsy D Kennard
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390 8589, USA
    Child Adolesc Psychiatr Clin N Am 15:1057-79, xi. 2006
    ..Lack of consistent efficacy in acute treatment studies has limited long-term prevention treatment research in pediatric depression. The impact of long-term treatments, both psychosocial and pharmacologic, is currently unknown...
  28. ncbi request reprint Sleep microarchitecture as a predictor of recurrence in children and adolescents with depression
    Roseanne Armitage
    Psychiatry Department, University of Texas Southwestern Medical Center at Dallas, TX 75390 9070, USA
    Int J Neuropsychopharmacol 5:217-28. 2002
    ..Significant sex differences were found with a stronger relationship between temporal coherence and clinical course in boys. This study supports the use of quantitative sleep EEG measures as a predictor of clinical course in depression...
  29. ncbi request reprint Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms
    Christopher J Kratochvil
    Department of Psychiatry, Nebraska Medical Center, Omaha 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 44:915-24. 2005
    ..The authors assessed the safety and effectiveness of atomoxetine monotherapy compared with combined atomoxetine/fluoxetine therapy in a population of children and adolescents with ADHD and concurrent symptoms of depression or anxiety...
  30. ncbi request reprint Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy
    Graham J Emslie
    Child and Adolescent Psychiatry Division, University of Texas Southwestern Medical Center at Dallas, Dallas, USA
    J Clin Psychiatry 66:14-20. 2005
    ....
  31. pmc A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine
    Paul A Nakonezny
    Division of Biostatistics, Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas 75390 8828, USA
    J Child Adolesc Psychopharmacol 20:431-9. 2010
    ..We then suggested recommendations for clinical researchers and practicing clinicians regarding medication adherence assessment...
  32. doi request reprint Brain activity in adolescent major depressive disorder before and after fluoxetine treatment
    Rongrong Tao
    Department of Psychiatry, The Department of Neurology, the Division of Biostatistics of the Department of Clinical Sciences, and the Advanced Imaging Center, University of Texas Southwestern Medical Center at Dallas, USA
    Am J Psychiatry 169:381-8. 2012
    ....
  33. ncbi request reprint Antidepressant management in the context of suicidal ideation
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, TX, USA
    J Am Acad Child Adolesc Psychiatry 46:1222-5. 2007
  34. ncbi request reprint Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, USA
    J Am Acad Child Adolesc Psychiatry 41:1205-15. 2002
    ..This report presents results from the acute treatment phase of a clinical trial designed to confirm efficacy of a fixed dose of 20 mg of fluoxetine in children and adolescents with major depressive disorder (MDD)...
  35. ncbi request reprint Cognitions and depressive symptoms among ethnic minority adolescents
    Betsy D Kennard
    Psychiatry Department, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Cultur Divers Ethnic Minor Psychol 12:578-91. 2006
    ..Our findings demonstrate support for the cognitive model of depression across ethnic groups. The importance of controlling for social class when examining ethnic differences in psychological variables is highlighted by our findings...
  36. ncbi request reprint Effect of structured interviews on evaluation time in pediatric community mental health settings
    Carroll W Hughes
    Department of Psychiatry, University of Texas Southwestern Medical Center, 5232 Harry Hines Boulevard, Dallas, Texas 75390, USA
    Psychiatr Serv 56:1098-103. 2005
    ....
  37. ncbi request reprint Adolescent suicide attempters in Hong Kong and the United States
    Sunita M Stewart
    UT Southwestern Medical Center at Dallas, TX, USA
    Soc Sci Med 63:296-306. 2006
    ..These findings do not support the proposition that depression is a less relevant variable in suicide attempts in Chinese versus western groups...
  38. pmc The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder
    E Sherwood Brown
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8849, USA
    Ann Allergy Asthma Immunol 100:433-8. 2008
    ..Despite the high co-occurrence between depression and asthma, few studies have addressed methods assessing the severity of depressive symptoms among patients with asthma...
  39. doi request reprint Increased cortical excitability with prefrontal high-frequency repetitive transcranial magnetic stimulation in adolescents with treatment-resistant major depressive disorder
    Paul E Croarkin
    Division of Child and Adolescent Psychiatry, Department of Psychiatry, UT Southwestern Medical Center Dallas, Dallas, Texas 75390 8589, USA
    J Child Adolesc Psychopharmacol 22:56-64. 2012
    ..To examine changes in motor cortical excitability in adolescent subjects receiving 30 sessions of high-frequency prefrontal repetitive transcranial magnetic stimulation (rTMS)...
  40. ncbi request reprint A cross-cultural investigation of cognitions and depressive symptoms in adolescents
    Sunita Mahtani Stewart
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 75390 8589, USA
    J Abnorm Psychol 113:248-57. 2004
    ..There was some support for the hypothesis that self-efficacy is less salient in collective compared with individualistic cultures. These findings extend cognitive theories of depression to a non-Western culture...
  41. pmc A preliminary investigation of corpus callosum and anterior commissure aberrations in aggressive youth with bipolar disorders
    Kirti Saxena
    Department of Psychiatry, University of Texas Health Science Center at Houston, Houston, Texas 77054, USA
    J Child Adolesc Psychopharmacol 22:112-9. 2012
    ....
  42. ncbi request reprint Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases
    Paul E Croarkin
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
    J Clin Psychiatry 69:1157-65. 2008
    ....
  43. ncbi request reprint Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus
    Sunita M Stewart
    Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 8589, USA
    Pediatrics 115:1315-9. 2005
    ..To examine the role of self-reported depressive symptoms in predicting hospitalization for complications of diabetes mellitus over a period of up to 2 years...
  44. ncbi request reprint A feasibility study of the children's medication algorithm project (CMAP) algorithm for the treatment of ADHD
    Steven R Pliszka
    University of Texas Health Science Center at San Antonio, Texas 8229 3900, USA
    J Am Acad Child Adolesc Psychiatry 42:279-87. 2003
    ..To determine whether an algorithm for the treatment of attention-deficit/hyperactivity disorder (ADHD) can be implemented in a community mental health center...
  45. pmc The use of antidepressants to treat depression in children and adolescents
    Amy H Cheung
    Department of Psychiatry, University of Toronto, Toronto, Ont
    CMAJ 174:193-200. 2006
    ..In addition, we discuss methodologic issues and clinical implications specific to the pediatric population...
  46. ncbi request reprint Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression
    Mark E Bangs
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    J Child Adolesc Psychopharmacol 17:407-20. 2007
    ..ATX was an effective and safe treatment for ADHD in adolescents with ADHD and MDD. However, this trial showed no evidence for ATX of efficacy in treating MDD...
  47. ncbi request reprint Psychopharmacological treatment for very young children: contexts and guidelines
    Mary Margaret Gleason
    Bradley Hasbro Research Center, Providence, RI 02903, USA
    J Am Acad Child Adolesc Psychiatry 46:1532-72. 2007
    ..The purpose of this effort is to promote responsible treatment of young children, recognizing that this will sometimes involve the use of medications...
  48. ncbi request reprint Citalopram in children and adolescents with depression or anxiety
    Jennifer L Baumgartner
    College of Pharmacy, University of Texas, Texas Department of Mental Health and Mental Retardation, Austin, USA
    Ann Pharmacother 36:1692-7. 2002
    ..To investigate the efficacy and tolerability of citalopram in children and adolescents...
  49. ncbi request reprint Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder
    Joseph Biederman
    Massachusetts General Hospital, Boston, Massachusetts, USA
    Pediatrics 110:e75. 2002
    ..Atomoxetine is a potent inhibitor of the presynaptic norepinephrine transporter with minimal affinity for other noradrenergic receptors or for other neurotransmitter transporters or receptors...
  50. ncbi request reprint Validation of the Mood Disorder Questionnaire for bipolar disorders in adolescents
    Karen Dineen Wagner
    Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston 77555 0188, USA
    J Clin Psychiatry 67:827-30. 2006
    ....
  51. ncbi request reprint A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents
    Karen Dineen Wagner
    Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77755 0188, USA
    Am J Psychiatry 163:1179-86. 2006
    ..This multicenter trial examined the efficacy and safety of oxcarbazepine in the treatment of bipolar disorder in children and adolescents...
  52. ncbi request reprint Review of the efficacy and safety of antidepressants in youth depression
    Amy H Cheung
    Department of Psychiatry, University of Toronto, Ontario, Canada
    J Child Psychol Psychiatry 46:735-54. 2005
    ..This review examined the available evidence from clinical trials of antidepressants in adolescents and children with depression...
  53. ncbi request reprint A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatology
    Heidi K Moore
    Healthcare Technology Systems, Inc, Madison, WI 53717, USA
    J Clin Psychiatry 68:1436-40. 2007
    ..An adolescent version of the QIDS (QIDS-A-IVR) was created using speaker-independent voice recognition technology. An informant version, QIDS-P-IVR, collects ratings from parents or other knowledgeable adults...
  54. doi request reprint Improving outcome in pediatric depression
    Graham J Emslie
    Am J Psychiatry 165:1-3. 2008
  55. ncbi request reprint National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders
    Dennis S Charney
    Division of Intramural Research Programs, National Institute of Mental Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Arch Gen Psychiatry 59:262-70. 2002
    ..Research is needed on the ethical conduct of studies to limit risks of medication-free intervals and facilitate poststudy treatment. Patients must fully understand the risks and lack of individualized treatment involved in research...

Research Grants18

  1. CHILDHOOD DEPRESSION-BIOLOGICAL CORRELATES
    Graham Emslie; Fiscal Year: 1992
    ..Clinically antidepressants are widely used in treatment of depression in this age group and yet controlled studies are limited. If medication is effective in some then it would be important to determine in whom...
  2. Pediatric MDD: Sequential Treatment with Fluoxetine and Relapse Prevention CBT
    Graham Emslie; Fiscal Year: 2009
    ....
  3. Child Psychiatry Research Education Program (C-PREP)
    Graham Emslie; Fiscal Year: 2007
    ....
  4. TREATMENT OF SSRI-RESISTANT DEPRESSION IN ADOLESCENTS
    Graham Emslie; Fiscal Year: 2006
    ..This site is based in Pittsburgh, which also serves as the Data Coordinating Center for the study ..
  5. Treatment of Adolescent Suicide Attempters in Dallas
    Graham Emslie; Fiscal Year: 2006
    ..This exemplary protocol stimulated the formation of a collaborative group of 8 RUPP-PI applicants. By creating the protocol, the group forged an ability to work together. ..
  6. CHILDHOOD DEPRESSION: REMISSION AND RELAPSE
    Graham Emslie; Fiscal Year: 2004
    ..The primary outcome variable will be response to acute treatment and relapse during continuation phase treatment. There have been no studies of need for continuation treatment in depression in the pediatric age group. ..
  7. Treatment of Early Age Mania (TEAM)
    Graham Emslie; Fiscal Year: 2003
    ..D. (4) University of Texas, Dallas, PI: Graham Emslie, M.D. (5) University of Texas, Galveston, PI: Karen Dineen Wagner, M.D. and (6) Washington University, St. Louis, PI; Joan Luby, M.D. ..
  8. CHILDHOOD DEPRESSION: REMISSION AND RELAPSE
    Graham Emslie; Fiscal Year: 2003
    ..The primary outcome variable will be response to acute treatment and relapse during continuation phase treatment. There have been no studies of need for continuation treatment in depression in the pediatric age group. ..
  9. Treatment of Adolescent Suicide Attempters in Dallas
    Graham Emslie; Fiscal Year: 2002
    ..This exemplary protocol stimulated the formation of a collaborative group of 8 RUPP-PI applicants. By creating the protocol, the group forged an ability to work together. ..
  10. CHILDHOOD DEPRESSION: REMISSION AND RELAPSE
    Graham Emslie; Fiscal Year: 2002
    ..The primary outcome variable will be response to acute treatment and relapse during continuation phase treatment. There have been no studies of need for continuation treatment in depression in the pediatric age group. ..
  11. CHILDHOOD DEPRESSION: REMISSION AND RELAPSE
    Graham Emslie; Fiscal Year: 2001
    ..The primary outcome variable will be response to acute treatment and relapse during continuation phase treatment. There have been no studies of need for continuation treatment in depression in the pediatric age group. ..
  12. CHILDHOOD DEPRESSION-BIOLOGICAL CORRELATES
    Graham Emslie; Fiscal Year: 1993
    ..Clinically antidepressants are widely used in treatment of depression in this age group and yet controlled studies are limited. If medication is effective in some then it would be important to determine in whom...
  13. Pediatric MDD: Sequential Treatment with Fluoxetine and Relapse Prevention CBT
    Beth D Kennard; Fiscal Year: 2010
    ....